Radium-223 chloride: Radiation safety, tolerability, and survival gain in patients with castration-resistant prostate cancer (CRPC) and bone metastases

被引：0
|
作者：
Lewington, Valerie [1 ]
Lamey, Roy [2 ]
Staudacher, Karin [3 ]
Vogelzang, Nicholas [2 ]
机构：
[1] Guys & St Thomas Hosp, London, England
[2] Comprehens Canc Ctr Nevada, US Oncol Res, Las Vegas, NV USA
[3] Algeta ASA, Oslo, Norway
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
222
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases
    Hiroji Uemura
    Hirotsugu Uemura
    Nobuaki Matsubara
    Seigo Kinuya
    Makoto Hosono
    Yoko Yajima
    Toshihiko Doi
    International Journal of Clinical Oncology, 2017, 22 : 954 - 963
  • [2] Efficacy and Safety of Radium-223 Dichloride in the Treatment of Patients with Castration-Resistant Prostate Cancer with Bone Metastases
    Sanchez Lopez, Hector
    GACETA MEXICANA DE ONCOLOGIA, 2016, 15 : 1 - 2
  • [3] Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases
    Uemura, Hiroji
    Uemura, Hirotsugu
    Matsubara, Nobuaki
    Kinuya, Seigo
    Hosono, Makoto
    Yajima, Yoko
    Doi, Toshihiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (05) : 954 - 963
  • [4] Alkaline phosphatase (ALP) normalization and overall survival in patients with bone metastases from castration-resistant prostate cancer (CRPC) treated with radium-223
    Parker, C.
    O'Bryan-Tear, C. G.
    Bolstad, B.
    Lokna, A.
    Nilsson, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [5] Radium-223 Chloride Safety and Use of External Beam Radiation Therapy (EBRT) in the Phase HI Randomized Trial (ALSYMPCA) in Patients With Castration-resistant Prostate Cancer (CRPC) and Bone Metastases
    Sandler, H. M.
    Nilsson, S.
    Parker, C.
    Garcia-Vargas, J.
    Staudacher, K.
    Hoskin, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S3 - S4
  • [6] A phase I/IIa study of the safety and efficacy of radium-223 chloride (Ra-223) with docetaxel (D) for castration-resistant prostate cancer (CRPC) patients with bone metastases.
    Morris, Michael J.
    Hammers, Hans J.
    Sweeney, Christopher
    Bloma, Marianne
    Aksnes, Anne-Kirsti
    O'Bryan-Tear, C. Gillies
    Carrasquillo, Jorge A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Safety of cytotoxic chemotherapy following Radium-223 Chloride (Ra-223) therapy in the phase 3 alsympca study in patients with Castration-resistant Prostate Cancer (CRPC) with Bone Metastases
    Stroelin, P.
    Sartor, O.
    Coleman, R. E.
    Nilsson, S.
    Vogelzang, N.
    Cross, A.
    Tear, C. G. O'Bryan
    Staudacher, K.
    Vargas, J. E. Garcia
    Zou, J.
    Parker, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 60 - 60
  • [8] Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why
    Gallicchio, Rosj
    Mastrangelo, Pietro A.
    Nardelli, Anna
    Mainenti, Pier Paolo
    Colasurdo, Antonio P.
    Landriscina, Matteo
    Guglielmi, Giuseppe
    Storto, Giovanni
    TUMORI JOURNAL, 2019, 105 (05): : 367 - 377
  • [9] SAFETY OF CYTOTOXIC CHEMOTHERAPY FOLLOWING RADIUM-223 CHLORIDE (RA-223) THERAPY IN THE PHASE 3 ALSYMPCA STUDY IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC) WITH BONE METASTASES
    Sartor, O.
    Coleman, R. E.
    Nilsson, S.
    Vogelzang, N.
    Cross, A.
    O'Bryan-Tear, G.
    Staudacher, K.
    Garcia-Vargas, J. E.
    Zou, J.
    Parker, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 308 - 309
  • [10] Radium-223 dichloride for the treatment of castration-resistant prostate cancer with symptomatic bone metastases
    Vogelzang, Nicholas J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (08) : 809 - 819
12345